We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NVAX market cap is 1.3B. The company's latest EPS is USD -3.4027 and P/E is -2.35.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 424.43M | 186.99M | 291.34M | 93.86M | 415.48M |
| Operating Income | 55.46M | -125.63M | -183.57M | -144.83M | 161M |
| Net Income | 58.01M | -130.78M | -178.39M | -147.55M | 162.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 18.66M | 475.6M | 1.15B | 1.98B | 983.71M |
| Operating Income | -129.6M | -416.72M | -1.69B | -644.74M | -566.51M |
| Net Income | -132.69M | -418.26M | -1.74B | -657.94M | -545.06M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.69B | 1.66B | 1.8B | 1.35B | 1.82B |
| Total Liabilities | 2.44B | 2.34B | 2.51B | 2.22B | 2.25B |
| Total Equity | -754.52M | -678.35M | -716.93M | -867.08M | -431.71M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 172.96M | 1.58B | 2.58B | 2.26B | 1.8B |
| Total Liabilities | 358.97M | 955.27M | 2.93B | 2.89B | 2.51B |
| Total Equity | -186.02M | 627.21M | -351.67M | -634.08M | -716.93M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -497.53M | -537.19M | -713.97M | -83.56M | 230.71M |
| Investing | -31.34M | -49.73M | -58.81M | -7.25M | -379.96M |
| Financing | -293.04M | -95.92M | 4.47M | 5.89M | 264.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -136.62M | -42.54M | 322.95M | -415.94M | -713.97M |
| Investing | 38.49M | -377.78M | 100.15M | -92.99M | -58.81M |
| Financing | 98.38M | 984.76M | 461.71M | 324.99M | 4.47M |
| Market Cap | 1.3B |
| Price to Earnings Ratio | -2.35 |
| Price to Sales Ratio | 1.3 |
| Price to Cash Ratio | 2.25 |
| Price to Book Ratio | -1.78 |
| Dividend Yield | - |
| Shares Outstanding | 160.18M |
| Average Volume (1 week) | 6.45M |
| Average Volume (1 Month) | 5.73M |
| 52 Week Change | 43.98% |
| 52 Week High | 23.8599 |
| 52 Week Low | 3.5324 |
| Spread (Intraday) | 0.01 (0.12%) |
| Company Name | Novavax Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.novavax.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
